
Pharma Pulse 7/10/24: Study Connects Multivitamin Use With Mortality Risk, Can Data and AI Deliver Whole-Person Health? & more
The latest news for pharma industry insiders.
Executives in the life sciences and medical device industries see promise in artificial intelligence (AI) and medical technologies, but must also navigate the changing healthcare ecosystem, varied stakeholder needs, and the impact of AI on market access and commercialization strategies.
Daily multivitamin users were associated with a 4% higher mortality risk compared to nonusers.
A security breach at the maker of ChatGPT last year revealed internal discussions among researchers and other employees, but not the code behind OpenAI’s systems.
Biostate AI emerges with the launch of two service products: Total RNA sequencing and Copilot for RNAseq data analysis. Biostate AI aims to partner and collaborate with academic researchers, hospital biorepositories, and pharma/biotech companies, leveraging its new technologies for scalable multiomic data collection, scientific discovery, and AI training.
The #biopharma sector is amidst significant transformations. Partly caused by inflated salaries from the spike in need in 2020. Knowing when to use new tech such as AI is key for a leader in the current climate. #Biotech #Technology
Have news you want us to share in Pharma Pulse? Reach out to Social Media Editor
Newsletter
Stay ahead in the life sciences industry with Pharmaceutical Commerce, the latest news, trends, and strategies in drug distribution, commercialization, and market access.

